Therapy News and Research

RSS

World Vision reports on healthcare resources

Global efforts to tackle millions of preventable child and maternal deaths will fail to extend gains unless world leaders act now to pour more healthcare resources directly into families and communities, according to a new World Vision report launched today.

17 Sep 2010

Inspire Pharmaceuticals to present denufosol tetrasodium therapy data at ERS Annual Congress

Inspire Pharmaceuticals, Inc. announced today that data will be presented on denufosol tetrasodium, an investigational therapy for cystic fibrosis (CF), during oral and poster presentations at the European Respiratory Society (ERS) Annual Congress September 18 - 22, 2010 in Barcelona, Spain.

17 Sep 2010

Transition stops TT-223 gastrin analogue combination clinical study in type 2 diabetes

Transition Therapeutics Inc. announced today that a clinical study of gastrin analogue TT-223 in combination with a Lilly proprietary GLP-1 analogue in patients with type 2 diabetes did not meet its efficacy endpoints. Given these findings, there will be no further development of TT-223.

17 Sep 2010

Global regulator for DNA trade needed

Amid growing concern that synthetic life sciences pose biosecurity and biosafety risks, scrutiny is increasing into the burgeoning DNA sequence trade. Research published today in the Bulletin of the Atomic Scientists, published by SAGE, looks at the necessity of a global regulator for DNA trade, and the significant barriers to creating one.

17 Sep 2010

Spike mat reduces muscle tension pain: Study

Spike mats do not alleviate chronic pain. Nor do they lead to a better night's sleep. But pain sufferers who have tested a spike mat did experience a measurable reduction in the worst peaks of pain. This is shown in a research study performed at Karlstad University in Sweden.

17 Sep 2010

Vital Therapies expands SILVER clinical trial to Middle East

Vital Therapies, Inc., is pleased to announce that the first subject has been enrolled at National Guard Hospital in Riyadh, Kingdom of Saudi Arabia in the further expansion of its SILVER clinical trial to the Middle East. The trial is evaluating whether VTI's biological cellular therapy product, ELAD, can prevent deterioration of liver function and improve the survival of patients with acute-on-chronic liver failure.

17 Sep 2010

Prometheus, Tarrot announce exclusive agreement for Crohn's Disease treatment

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, today announced the execution of an exclusive research collaboration and license agreement. The collaboration will focus on identifying genetic or serologic markers associated with clinical responses to anti-TNF therapies such as Cimzia, Humira and Remicade utilized in the treatment of Crohn's Disease, and the subsequent development of diagnostic tests.

17 Sep 2010

Shrink Nanotechnologies files patent for CellAlign tissue engineering technology

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that certain patent applications related to its advanced tissue engineering technology platform, CellAlign, have been filed.

17 Sep 2010

Research on signaling pathways may help to design therapy for neurodevelopmental disorders

Researchers at the Center for Neuroscience Research at Children's National Medical Center have discovered that the two major types of signaling pathways activated during brain cell development-the epidermal growth factor receptor pathway and the Notch pathway-operate together to determine how many and which types of brain cells are created during growth and repair in developing and adult brains.

17 Sep 2010

New imaging technique visualizes myocardial scar and heart's blood vessels simultaneously

Cardiologists and surgeons may soon have a new tool to improve outcomes for patients requiring pacemakers, bypass surgery or angioplasties. Research led by Dr. James White and his colleagues at The University of Western Ontario has led to a new imaging technique, which provides a single, 3D high-resolution image of the heart revealing both its vasculature and the presence of scar tissue within the muscle.

17 Sep 2010

Scientists discover new drug target to improve radiation effectiveness for treating cancer

Scientists at Washington University School of Medicine in St. Louis have discovered a new drug target that could improve the effectiveness of radiation for hard-to-treat cancers.

17 Sep 2010

Study finds no link between asthma and tooth decay

There is no apparent link between asthma and tooth decay, according to a study published in the September 2010 issue of the Journal of the American Dental Association.

17 Sep 2010

New anti-pathogenic drugs render MRSA harmless without killing bacteria

Menachem Shoham, PhD, associate professor and researcher in the department of biochemistry at the Case Western Reserve University School of Medicine, has identified new anti-pathogenic drugs that, without killing the bacteria, render Methicillin Resistant Staphylococcus Aureus (MRSA) harmless by preventing the production of toxins that cause disease.

17 Sep 2010

ResMed's new CPAP device increases patients' compliance with sleep therapy

ResMed, a leading developer, manufacturer, and distributor of sleep and respiratory medical equipment today announced the results of a clinical study confirming that patients' compliance with sleep therapy increases when using ResMed's new CPAP device.

From ResMed Corp 17 Sep 2010

Illinois CDH Proton Center to open ahead of schedule in October

Proton therapy, an alternative to radiation for the treatment of cancer, will be available in Illinois sooner than expected. Originally slated to open in early 2011, the CDH Proton Center, A ProCure Center, will open its doors Oct. 19, making it the first proton therapy center in Illinois and only the ninth in the country.

17 Sep 2010

FDA approves expanded indication for Boston Scientific's CRT-Ds

Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The exclusive expanded indication is effective immediately and makes Boston Scientific CRT-Ds the only devices approved by the FDA for patients in all New York Heart Association (NYHA) classes of heart failure.

17 Sep 2010

Medtronic Deep Brain Stimulation Therapy for severe epilepsy receives CE Mark approval

Medtronic, Inc. today announced that the company has received CE (Conformité Européenne) Mark approval for Medtronic Deep Brain Stimulation (DBS) Therapy in Europe as adjunctive treatment for partial-onset seizures in adults with medically refractory epilepsy. DBS therapy for epilepsy delivers controlled electrical pulses to a target in the brain called the anterior nucleus of the thalamus, which is part of a circuit involved in seizures.

17 Sep 2010

FDA approves CRT-D device to treat heart failure patients

The U.S. Food and Drug Administration today approved a new indication for three cardiac resynchronization therapy defibrillators (CRT-D) used to treat certain heart failure patients.

17 Sep 2010

Scientists discover protein to regulate blood stem cells’ activity for leukemia treatment

A discovery made by Dr. Tarik Möröy, President and Scientific Director and Director of the IRCM, and his team was recently published in Blood, the official journal of the American Society of Hematology. The researchers found that a protein can regulate certain characteristics of blood stem cells, which could lead to a better treatment for leukemia patients.

17 Sep 2010

Abbott to present two drug eluting stents data at TCT symposium

Abbott today announced the company's schedule of key data presentations at the Cardiovascular Research Foundation's 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C., to be held Sept. 21 – 25.

17 Sep 2010

Therapy News and Research

World Vision reports on healthcare resources

Inspire Pharmaceuticals to present denufosol tetrasodium therapy data at ERS Annual Congress

Transition stops TT-223 gastrin analogue combination clinical study in type 2 diabetes

Global regulator for DNA trade needed

Spike mat reduces muscle tension pain: Study

Vital Therapies expands SILVER clinical trial to Middle East

Prometheus, Tarrot announce exclusive agreement for Crohn's Disease treatment

Shrink Nanotechnologies files patent for CellAlign tissue engineering technology

Research on signaling pathways may help to design therapy for neurodevelopmental disorders

New imaging technique visualizes myocardial scar and heart's blood vessels simultaneously

Scientists discover new drug target to improve radiation effectiveness for treating cancer

Study finds no link between asthma and tooth decay

New anti-pathogenic drugs render MRSA harmless without killing bacteria

ResMed's new CPAP device increases patients' compliance with sleep therapy

Illinois CDH Proton Center to open ahead of schedule in October

FDA approves expanded indication for Boston Scientific's CRT-Ds

Medtronic Deep Brain Stimulation Therapy for severe epilepsy receives CE Mark approval

FDA approves CRT-D device to treat heart failure patients

Scientists discover protein to regulate blood stem cells’ activity for leukemia treatment

Abbott to present two drug eluting stents data at TCT symposium

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News